What is Quest Diagnostics Inc. share price today?

Quest Diagnostics Inc. (DGX) share price today is {{live_price}}.

Can Indians buy Quest Diagnostics Inc. shares?

Yes, Indians can invest in the Quest Diagnostics Inc. (DGX) from India. With INDmoney, you can buy Quest Diagnostics Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Quest Diagnostics Inc. at zero transaction cost.

How can I buy Quest Diagnostics Inc. shares from India?

It is very easy to buy Quest Diagnostics Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quest Diagnostics Inc. be purchased?

Yes, you can buy fractional shares of Quest Diagnostics Inc. with INDmoney app.

What are the documents required to start investing in Quest Diagnostics Inc. stocks?

To start investing in Quest Diagnostics Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Quest Diagnostics Inc.

Today’s highest price of Quest Diagnostics Inc. (DGX) is {{1_rba_end}}. Today’s lowest price of Quest Diagnostics Inc. (DGX) is {{1_rba_st}}.

What is today's market capitalisation of Quest Diagnostics Inc.

Today's market capitalisation of Quest Diagnostics Inc. DGX is 15.2B

What is the 52 Week High and Low Range of Quest Diagnostics Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Quest Diagnostics Inc. is down from its 52 Week High?

Quest Diagnostics Inc. (DGX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Quest Diagnostics Inc. is up from its 52 Week low?

Quest Diagnostics Inc. (DGX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Quest Diagnostics Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Quest Diagnostics Inc.

Mr. Stephen H. Rusckowski is the current Chief Executive Officer (CEO) of Quest Diagnostics Inc..

Home

US Stocks

Quest Diagnostics Inc.

Quest Diagnostics Inc. (DGX)

$134.55

-1.12

(-0.83%)▲

Market is closed - opens 7 PM, 12 Jun 2023

Performance

$134.24
$135.58
$134.55
0.23%
Downside
Day's Volatility :0.98%
Upside
0.76%
$119.16
$157.55
$134.55
11.44%
Downside
52 Weeks Volatility :24.37%
Upside
14.6%

Returns

Period	Quest Diagnostics Inc.
3 Months	1.01%
6 Months	-8.95%
1 Year	2.51%
3 Years	17.71%

Highlights

Market Capitalization	15.2B
Book Value	$54.02
Dividend Share	2.69
Dividend Yield	2.13%
Earnings Per Share (EPS)	6.77
PE Ratio	15.78
PEG Ratio	1.24
Wall Street Target Price	146.93

Profit Margin	8.26%
Operating Margin TTM	14.07%

Return On Assets TTM	6.44%
Return On Equity TTM	1269.82%

Revenue TTM	9.6B
Revenue Per Share TTM	84.05
Quarterly Revenue Growth YOY	-10.7%
Gross Profit TTM	3.5B
EBITDA	1.8B
Diluted Eps TTM	6.83
Quarterly Earnings Growth YOY	-0.39

EPS Estimate Current Year	8.73
EPS Estimate Next Year	9.1
EPS Estimate Current Quarter	1.97
EPS Estimate Next Quarter	2.25

Analyst Recommendation

Hold

36%Buy

63%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Quest Diagnostics Inc.(by analysts ranked 0 to 5 stars)

Based on 22 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 9.2%

Current $134.55

Target $146.93

Company Financials

	FY17	Y/Y Change
Revenue	7.7B	↑ 2.58%
Net Income	772.0M	↑ 19.69%
Net Profit Margin	10.01%	↑ 1.43%

	FY18	Y/Y Change
Revenue	7.5B	↓ 2.31%
Net Income	736.0M	↓ 4.66%
Net Profit Margin	9.77%	↓ 0.24%

	FY19	Y/Y Change
Revenue	7.7B	↑ 2.59%
Net Income	858.0M	↑ 16.58%
Net Profit Margin	11.11%	↑ 1.34%

	FY20	Y/Y Change
Revenue	9.4B	↑ 22.15%
Net Income	1.4B	↑ 66.78%
Net Profit Margin	15.16%	↑ 4.05%

	FY21	Y/Y Change
Revenue	10.8B	↑ 14.32%
Net Income	2.0B	↑ 39.41%
Net Profit Margin	18.49%	↑ 3.33%

	FY22	Y/Y Change
Revenue	9.9B	↓ 8.39%
Net Income	946.0M	↓ 52.58%
Net Profit Margin	9.57%	↓ 8.92%

	Q4 FY21	Q/Q Change
Revenue	2.7B	↓ 1.08%
Net Income	390.0M	↓ 22.77%
Net Profit Margin	14.21%	↓ 3.99%

	Q1 FY22	Q/Q Change
Revenue	2.6B	↓ 4.85%
Net Income	355.0M	↓ 8.97%
Net Profit Margin	13.6%	↓ 0.61%

	Q2 FY22	Q/Q Change
Revenue	2.5B	↓ 6.05%
Net Income	234.0M	↓ 34.08%
Net Profit Margin	9.54%	↓ 4.06%

	Q3 FY22	Q/Q Change
Revenue	2.5B	↑ 1.35%
Net Income	256.0M	↑ 9.4%
Net Profit Margin	10.3%	↑ 0.76%

	Q4 FY22	Q/Q Change
Revenue	2.3B	↓ 6.15%
Net Income	101.0M	↓ 60.55%
Net Profit Margin	4.33%	↓ 5.97%

	Q1 FY23	Q/Q Change
Revenue	2.3B	↓ 0.09%
Net Income	202.0M	↑ 100.0%
Net Profit Margin	8.67%	↑ 4.34%

	FY17	Y/Y Change
Total Assets	10.5B	↑ 3.99%
Total Liabilities	5.5B	↑ 1.99%

	FY18	Y/Y Change
Total Assets	11.0B	↑ 4.76%
Total Liabilities	5.7B	↑ 3.39%

	FY19	Y/Y Change
Total Assets	12.8B	↑ 16.72%
Total Liabilities	7.2B	↑ 24.76%

	FY20	Y/Y Change
Total Assets	14.0B	↑ 9.21%
Total Liabilities	7.2B	↑ 0.85%

	FY21	Y/Y Change
Total Assets	13.6B	↓ 2.96%
Total Liabilities	7.1B	↓ 1.23%

	FY22	Y/Y Change
Total Assets	12.8B	↓ 5.69%
Total Liabilities	6.9B	↓ 2.58%

	Q4 FY21	Q/Q Change
Total Assets	13.6B	↑ 0.29%
Total Liabilities	7.1B	↓ 0.17%

	Q1 FY22	Q/Q Change
Total Assets	13.4B	↓ 1.24%
Total Liabilities	6.9B	↓ 2.51%

	Q2 FY22	Q/Q Change
Total Assets	13.3B	↓ 0.97%
Total Liabilities	6.8B	↓ 2.36%

	Q3 FY22	Q/Q Change
Total Assets	13.2B	↓ 0.67%
Total Liabilities	6.9B	↑ 1.31%

	Q4 FY22	Q/Q Change
Total Assets	12.8B	↓ 2.92%
Total Liabilities	6.9B	↑ 1.02%

	Q1 FY23	Q/Q Change
Total Assets	12.8B	↓ 0.33%
Total Liabilities	6.7B	↓ 2.88%

	FY17	Y/Y Change
Operating Cash Flow	1.2B	↑ 9.92%
Investing Cash Flow	-805.0M	↑ 429.61%
Financing Cash Flow	-592.0M	↓ 14.33%

	FY18	Y/Y Change
Operating Cash Flow	1.2B	↑ 2.13%
Investing Cash Flow	-801.0M	↓ 0.5%
Financing Cash Flow	-401.0M	↓ 32.26%

	FY19	Y/Y Change
Operating Cash Flow	1.2B	↑ 3.58%
Investing Cash Flow	-411.0M	↓ 48.69%
Financing Cash Flow	225.0M	↓ 156.11%

	FY20	Y/Y Change
Operating Cash Flow	2.0B	↑ 61.3%
Investing Cash Flow	-772.0M	↑ 87.83%
Financing Cash Flow	-1.3B	↓ 663.11%

	FY21	Y/Y Change
Operating Cash Flow	2.2B	↑ 11.37%
Investing Cash Flow	21.0M	↓ 102.72%
Financing Cash Flow	-2.5B	↑ 100.47%

	FY22	Y/Y Change
Operating Cash Flow	1.7B	↓ 23.06%
Investing Cash Flow	-543.0M	↓ 2685.71%
Financing Cash Flow	-1.7B	↓ 31.81%

	Q4 FY21	Q/Q Change
Operating Cash Flow	481.0M	↓ 14.26%
Investing Cash Flow	-227.0M	↑ 136.46%
Financing Cash Flow	-369.0M	↑ 871.05%

	Q1 FY22	Q/Q Change
Operating Cash Flow	480.0M	↓ 0.21%
Investing Cash Flow	-169.0M	↓ 25.55%
Financing Cash Flow	-471.0M	↑ 27.64%

	Q2 FY22	Q/Q Change
Operating Cash Flow	402.0M	↓ 16.25%
Investing Cash Flow	-82.0M	↓ 51.48%
Financing Cash Flow	-242.0M	↓ 48.62%

	Q3 FY22	Q/Q Change
Operating Cash Flow	502.0M	↑ 24.88%
Investing Cash Flow	-118.0M	↑ 43.9%
Financing Cash Flow	-474.0M	↑ 95.87%

	Q4 FY22	Q/Q Change
Operating Cash Flow	1.7B	↑ 242.23%
Investing Cash Flow	-543.0M	↑ 360.17%
Financing Cash Flow	-1.7B	↑ 265.4%

	Q1 FY23	Q/Q Change
Operating Cash Flow	94.0M	↓ 94.53%
Investing Cash Flow	-158.0M	↓ 70.9%
Financing Cash Flow	-76.0M	↓ 95.61%

Technicals Summary

Sell

Neutral

Buy

Quest Diagnostics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quest Diagnostics Inc.	1.6%	-8.95%	2.51%	17.71%	20.51%
Idexx Laboratories, Inc.	-7.04%	6.58%	30.38%	40.09%	103.99%
Agilent Technologies Inc.	-9.58%	-25.46%	-3.96%	28.93%	75.09%
Thermo Fisher Scientific, Inc.	-2.87%	-8.71%	-1.65%	46.88%	138.42%
Danaher Corp.	0.83%	-13.94%	-6.41%	36.3%	127.98%
Iqvia Holdings Inc.	9.84%	-3.07%	-0.38%	40.36%	98.32%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quest Diagnostics Inc.	15.78	15.78	1.24	8.73	12.7	0.06	0.02	54.02
Idexx Laboratories, Inc.	55.24	55.24	7.21	9.69	0.94	0.22	0.0	10.13
Agilent Technologies Inc.	26.6	26.6	2.36	5.61	24.78	0.1	0.01	19.58
Thermo Fisher Scientific, Inc.	28.89	28.89	4.28	23.71	14.48	0.05	0.0	109.55
Danaher Corp.	25.34	25.34	3.24	8.79	0.14	0.06	0.0	68.31
Iqvia Holdings Inc.	35.29	35.29	1.48	10.42	17.8	0.05	0.0	31.98

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quest Diagnostics Inc.	Hold	$15.2B	20.51%	15.78	8.26%
Idexx Laboratories, Inc.	Buy	$37.6B	103.99%	55.24	20.38%
Agilent Technologies Inc.	Buy	$34.4B	75.09%	26.6	19.19%
Thermo Fisher Scientific, Inc.	Buy	$200.9B	138.42%	28.89	13.75%
Danaher Corp.	Buy	$173.7B	127.98%	25.34	22.4%
Iqvia Holdings Inc.	Buy	$38.3B	98.32%	35.29	7.28%

Institutional Holdings

Vanguard Group Inc
12.23%
BlackRock Inc
11.06%
State Street Corporation
5.07%
Victory Capital Management Inc.
2.80%
American Century Companies Inc
2.44%
Geode Capital Management, LLC
2.11%

Corporate Announcements

Quest Diagnostics Inc. Dividends December,2023
In the quarter ending December,2023. Quest Diagnostics Inc. has declared dividend of $0.71
Read More

Organization	Quest Diagnostics Inc.
Employees	40000
CEO	Mr. Stephen H. Rusckowski
Industry	Health Services